Sumatriptan Injection, Solution
Product Images NDC 51407-673

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Sumatriptan (NDC 51407-673). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-673-01 (Sumatriptan Injector Label 6 mg0.5 mL)

Sumatriptan Injection USP 6 mg/0.5 mL in a single-dose autoinjector system. The label states for subcutaneous injection only and is labeled by Golden State Medical Supply, Inc. Marketed by GSMS, Incorporated, Camarillo, CA. The product is from Spain. Includes dosage strength and autoinjector usage details.*

FDA Label Image

51407-673-02 (Sumatriptan Injector Carton 6 mg0.5 mL)

Sumatriptan Injection USP 6 mg/0.5 mL autoinjector system carton label from Golden State Medical Supply, Inc. The injectable solution is for subcutaneous use and comes in a box containing 2 autoinjectors, each a 0.5 mL prefilled syringe with 6 mg sumatriptan. The label includes step-by-step usage instructions with images, product NDC 51407-673-02, and warnings such as 'For subcutaneous injection only.'*

FDA Label Image

Sumatriptan-structure (7b0603f0 Ed39 460b 9d7b F19b95006024 01)

Chemical structure of sumatriptan showing its molecular composition with labeled functional groups including indole, sulfonamide, and ethylamine moieties.*

FDA Label Image

Device Image (7b0603f0 Ed39 460b 9d7b F19b95006024 02)

SUMATRIPTAN 6 mg/0.5 mL subcutaneous injection solution in a prefilled autoinjector device. The device has a white and blue plastic casing with a clear window showing the syringe inside. The label on the device includes dosage strength, administration route, and the labeler Golden State Medical Supply, Inc.*

FDA Label Image

Image Description (7b0603f0 Ed39 460b 9d7b F19b95006024 03)

An illustration of a sumatriptan injection autoinjector showing labeled parts including a gray cap, a transparent medicine window to check the liquid clarity, and a blue injection button that must be pressed firmly to start the injection. The diagram provides user instructions for correct device operation.*

FDA Label Image

Figure A (7b0603f0 Ed39 460b 9d7b F19b95006024 04)

An instructional illustration showing correct subcutaneous injection sites for SUMATRIPTAN injection, solution 6 mg/0.5 mL. The images depict a person administering the injection into the thigh in the first image and into the arm in the second image, indicating appropriate locations for self-injection.*

FDA Label Image

Figure B (7b0603f0 Ed39 460b 9d7b F19b95006024 05)

Illustration labeled 'Figure B Before Injection' showing a subcutaneous injection device containing a clear liquid, representing sumatriptan injection, solution 6 mg/0.5 mL before use.*

FDA Label Image

Figure C (7b0603f0 Ed39 460b 9d7b F19b95006024 06)

An instructional illustration labeled "Figure C," showing the sumatriptan injection device after administration. It highlights the blue plunger rod filling the window, indicating the completion of the injection process.*

FDA Label Image

Figure D (7b0603f0 Ed39 460b 9d7b F19b95006024 07)

Instructional illustration showing hands demonstrating how to pull the cap straight off a sumatriptan injection pen. The image is labeled as Figure D and includes directional arrows indicating the cap removal.*

FDA Label Image

Figure E (7b0603f0 Ed39 460b 9d7b F19b95006024 08)

Figure E shows two views of an injection device component for SUMATRIPTAN subcutaneous injection. The left side depicts the correct orientation with a green checkmark, while the right shows an incorrect orientation marked by a red X. The illustration guides proper device usage.*

FDA Label Image

Figure F (7b0603f0 Ed39 460b 9d7b F19b95006024 09)

An instructional illustration showing a hand holding a barrel-style injection device for subcutaneous administration. The device is pressed down at a 90-degree angle against the skin to unlock before injection, with a visual cue emphasizing pressing down to unlock.*

FDA Label Image

Figure G (7b0603f0 Ed39 460b 9d7b F19b95006024 10)

An instructional illustration showing a hand holding a sumatriptan injection device pressing down on the skin to administer a subcutaneous injection, with an arrow and 'Click' indicating the pressing action.*

FDA Label Image

Figure H (7b0603f0 Ed39 460b 9d7b F19b95006024 11)

An instructional illustration labeled "Figure H" showing a subcutaneous injection of SUMATRIPTAN 6 mg/0.5 mL. It depicts a hand holding the injector against the skin, highlighting the blue plunger moving down to completely fill medicine flow after injection.*

FDA Label Image

Figure I (7b0603f0 Ed39 460b 9d7b F19b95006024 12)

An instructional illustration depicting a hand administering a subcutaneous injection using a prefilled syringe. The image shows the syringe inserted into the skin, with a callout indicating to wait for 5 seconds before lifting up the syringe.*

FDA Label Image

Figure J (7b0603f0 Ed39 460b 9d7b F19b95006024 13)

Instructional illustration showing the use of a Sumatriptan autoinjector for subcutaneous injection. The image depicts a hand holding the autoinjector above the skin, with a directive to remove the device from the skin after administration.*

FDA Label Image

Figure K (7b0603f0 Ed39 460b 9d7b F19b95006024 14)

An illustration of a red biohazard sharps disposal container with a white lid, showing a warning label featuring the biohazard symbol and the word "WARNING" above it.*

FDA Label Image

Time To Relief Of Cluster Headache From Time Of Injectiona (7b0603f0 Ed39 460b 9d7b F19b95006024 17)

A line graph comparing the estimated percentage of patients with relief over time (minutes) between Sumatriptan and a placebo. The x-axis shows time in minutes from 0 to 25, and the y-axis shows the estimated percentage of patients with relief from 0 to 100%. The graph includes data points for Placebo (N=127) and Sumatriptan (N=131), with Sumatriptan consistently showing higher relief percentages over time.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.